Note: Ingredients listed on restricted chemical lists
EC/CAS
98-56-6
Name of the chemical
4-Chloro-alpha,alpha,alpha-trifluorotoluene
Concentration
10-30
General Information
Version
20
Revision date
2025-12-21
Product name
99BK004CAT CURING SOLUTION COMPONENT
1.2.1 Relevant identified uses
Industrial applications
Manufacturer Name
PPG Aerospace PRC-DeSoto
Icons in SDS
Company Information
company name
PPG Aerospace PRC-DeSoto
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H226, H315, H317, H319, H335, H351
Hazard statements
Code
Statements
H226
Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
Ingredient(s) with unknown acute toxicity
15.3% (dermal), 15.3% (inhalation)
Signal word
Warning
Hazard statements
Flammable liquid and vapor. Harmful if swallowed or if inhaled. Causes skin irritation. May cause an allergic skin reaction. Causes serious eye irritation. May cause respiratory irritation. Suspected of causing cancer.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Wear protective gloves, protective clothing and eye or face protection. Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. Use only outdoors or in a well-ventilated area. Avoid breathing vapor. Do not eat, drink or smoke when using this product. Wash thoroughly after handling. Contaminated work clothing must not be allowed out of the workplace.
Response
IF exposed or concerned Get medical advice or attention. IF INHALED Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER or doctor if you feel unwell. IF SWALLOWED: Call a POISON CENTER or doctor if you feel unwell. Rinse mouth. IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water. If skin irritation or rash occurs: Get medical advice or attention. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice or attention.
Storage
Store locked up. Store in a well-ventilated place. Keep container tightly closed.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations.
Supplemental label elements
Moisture-sensitive material. Repeated exposure to high vapor concentrations may cause irritation of the respiratory system and permanent brain and nervous system damage. Inhalation of vapor/aerosol concentrations above the recommended exposure limits causes headaches, drowsiness and nausea and may lead to unconsciousness or death. Skin contact to isocyanate monomer may lead to allergic lung reaction. Based on the properties of the isocyanate components and considering toxicological data on similar mixtures, this mixture may cause acute irritation and/or sensitization of the respiratory system, leading to an asthmatic condition, wheezing and tightness of the chest. Sensitized persons may subsequently show asthmatic symptoms when exposed to atmospheric concentrations well below the OEL. Repeated exposure may lead to permanent respiratory disability. Persons with a history of skin sensitization problems or asthma, allergies or chronic or recurrent respiratory disease should not be employed in any process in which this product is used. Avoid contact with skin and clothing. Wash thoroughly after handling. Emits toxic fumes when heated.
2.3 Other hazards
May form explosive peroxides. Hazardous reactions or instability may occur under certain conditions of storage or use. Prolonged or repeated contact may dry skin and cause irritation.
2.1 Classification of the substance or mixture
ACUTE TOXICITY (oral) - Category 4 ACUTE TOXICITY (inhalation) - Category 4 SKIN IRRITATION - Category 2 EYE IRRITATION - Category 2A SKIN SENSITIZATION - Category 1 CARCINOGENICITY - Category 2 SPECIFIC TARGET ORGAN TOXICITY (SINGLE EXPOSURE) (Respiratory tract irritation) - Category 3 Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 15.3% (dermal), 15.3% (inhalation)